Mitchell E. Levinson - 09 Jun 2022 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Reporting relationship: Chief Strategy Officer, Director
Issuer ticker: PLSE
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2022, 18:58:54 UTC
Prior SEC filing: 24 Mar 2023
Next SEC filing: 11 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact

Key filing fact

Mitchell E. Levinson filed Form 4 for Pulse Biosciences, Inc. (PLSE) on 10 Jun 2022.

Key facts

This page summarizes Mitchell E. Levinson's Form 4 filing for Pulse Biosciences, Inc. (PLSE).
10 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 10 Jun 2022, 18:58.

Change

Previous filing in this sequence was filed on 24 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +10,935
Change %: +41%
Price
Shares after: 37,504
Date: 09 Jun 2022
Ownership: Direct
Footnotes: F1, F2

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +814
Change %: +25%
Price
Shares after: 4,135
Date: 09 Jun 2022
Ownership: Spouse
Footnotes: F1, F2

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +143
Change %: +24%
Price
Shares after: 734
Date: 09 Jun 2022
Ownership: Immediate family member
Footnotes: F1, F2

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +143
Change %: +24%
Price
Shares after: 734
Date: 09 Jun 2022
Ownership: Immediate family member
Footnotes: F1, F2

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +143
Change %: +24%
Price
Shares after: 734
Date: 09 Jun 2022
Ownership: Immediate family member
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +10,935
Change %
Price
Shares after: 10,935
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,935
Exercise price: $2.05
Footnotes: F1, F2

PLSE transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +814
Change %
Price
Shares after: 814
Date: 09 Jun 2022
Ownership: Spouse
Underlying class: Common Stock
Underlying amount: 814
Exercise price: $2.05
Footnotes: F1, F2

PLSE transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +143
Change %
Price
Shares after: 143
Date: 09 Jun 2022
Ownership: Immediate family member
Underlying class: Common Stock
Underlying amount: 143
Exercise price: $2.05
Footnotes: F1, F2

PLSE transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +143
Change %
Price
Shares after: 143
Date: 09 Jun 2022
Ownership: Immediate family member
Underlying class: Common Stock
Underlying amount: 143
Exercise price: $2.05
Footnotes: F1, F2

PLSE transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +143
Change %
Price
Shares after: 143
Date: 09 Jun 2022
Ownership: Immediate family member
Underlying class: Common Stock
Underlying amount: 143
Exercise price: $2.05
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC.

Footnote F2

Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .